U.S. Online Retail and Ecommerce Stock News

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Those holding Frontier Group Holdings, Inc. ( NASDAQ:ULCC ) shares would be relieved that the share price has rebounded...

Over the past year, many Lennox International Inc. ( NYSE:LII ) insiders sold a significant stake in the company which...

We can readily understand why investors are attracted to unprofitable companies. For example, VirnetX Holding...

Energy Services of America Corporation ( NASDAQ:ESOA ) shares have had a horrible month, losing 26% after a relatively...

MYR Group's (NASDAQ:MYRG) stock is up by a considerable 18% over the past three months. Given that stock prices are...

Wondering if AtriCure at around $35 is quietly setting up a value opportunity, or if the market already has it priced just right? You are not alone in asking whether now is the moment to pay closer attention. The stock is up 16.2% year to date and 3.8% over the last month, even though it is still slightly down over 1 year and meaningfully lower over 3 and 5 years. This pattern hints at shifting sentiment and fresh expectations. Recent headlines have focused on AtriCure's progress in cardiac...

If you are wondering whether MannKind at around $5.59 is a hidden opportunity or a value trap, you are not alone, and that is exactly what we are going to unpack. The stock has slipped around 15.3% year to date and 17.8% over the past year, but it is still up 18.9% over 3 years and 98.2% over 5 years, which highlights how sentiment and risk perception have shifted over time. Recent attention on MannKind has centered on its inhaled insulin Afrezza and its expanding footprint in pulmonary...

TC Bancshares (TCBC) has just posted its Q3 2025 numbers, with revenue at about $4.9 million, basic EPS of $0.08 and quarterly net income of roughly $0.33 million, setting the tone for a cautiously constructive update. The company has seen revenue move from around $4.1 million in Q3 2024 to about $4.9 million in Q3 2025, while basic EPS shifted from roughly $0.06 to $0.08 over the same period, giving investors a clearer read on how recent profitability trends are feeding into the latest...

Wondering if Verisk Analytics is finally trading at a price that makes sense, or if the recent share moves are just noise in a data heavy story? The stock has inched up about 0.4% over the last week and 4.4% in the last month, but that comes after a tough stretch with shares still down 17.8% year to date and 22.4% over the past year, even though the three year and five year returns remain positive at 25.2% and 19.9% respectively. Recently, investors have been digesting updates around...

United Natural Foods (UNFI) opened fiscal Q1 2026 with revenue of about $7.8 billion and a basic EPS loss of roughly $0.07, alongside a trailing 12 month EPS of around negative $1.67 and net income of negative $101 million, keeping the bottom line in the red despite steady sales. The company has seen quarterly revenue move from $7.9 billion in Q1 2025 to $7.8 billion in Q1 2026, while basic EPS losses narrowed from about $0.35 a year ago and sat against a trailing 12 month revenue base of...

Kura Oncology recently reported that it completed the first U.S. commercial sale of KOMZIFTI (ziftomenib), its newly FDA-approved oral menin inhibitor for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, which also triggered a US$135,000,000 milestone payment from partner Kyowa Kirin expected before year-end 2025. This first sale, combined with KOMZIFTI’s inclusion in NCCN guidelines as a Category 2A recommended option, signals early clinical acceptance and provides an...

MongoDB (MDB) has just posted its Q3 2026 numbers, with revenue of about $628.3 million and basic EPS of roughly -$0.02, alongside net income excluding extra items of approximately -$2.0 million, marking another quarter where growth and profitability are still in tension. The company has seen quarterly revenue move from around $478.1 million in Q2 2025 to $628.3 million in Q3 2026. Basic EPS has swung between about -$0.74 and a brief positive patch of roughly $0.20 before landing at -$0.02...

NIP Group (NIPG) has kicked off H1 2025 with total revenue of about $45.9 million and basic EPS of roughly -$0.16, setting a cautious tone as the market digests another loss-making half. The company has seen revenue hover in the mid-$40 million range over recent periods, from about $45.1 million in H2 2023 to $39.3 million in H1 2024 and back to $45.9 million in H2 2024. Basic EPS stayed negative across the board, ranging from roughly -$1.64 to -$2.09 before the latest -$0.16 print. With the...

If you are looking at Vornado Realty Trust and wondering whether this beaten up New York office landlord is quietly turning into a value opportunity, you are not alone. The stock closed at $36.49 and is down 0.9% over the last week, 3.3% over the past month, and 14.4% year to date, but it is still up a hefty 79.1% over three years and 8.3% over five years, a reminder of how quickly sentiment around this name can swing. Those mixed returns sit against a backdrop of ongoing uncertainty around...

Simulations Plus (SLP) just closed FY 2025 with fourth quarter revenue of about $17.5 million and basic EPS of roughly -$0.03, capping a volatile year in which quarterly revenue swung between $17.5 million and $22.4 million while EPS ranged from a high of about $0.15 to a steep loss of roughly -$3.35. Over the last 12 months, the company booked about $79.2 million in revenue but remained unprofitable on a trailing basis, setting up a results season where investors are laser focused on whether...

Wondering whether First Advantage is a bargain or a value trap at today’s price? You are not alone. This article walks through what the numbers are really saying about the stock. The share price has slipped 3.7% over the last week, but it is still up 6.9% over the past month and remains well below where it started the year, down 26.7% year to date and 32.1% over the last 12 months, which has many investors reassessing its risk and reward profile. Recent headlines around tighter labor markets...

Citi Trends (CTRN) opened Q3 2026 with revenue of about $197.1 million and a basic EPS of roughly -$0.86, as net income excluding extra items came in around -$6.9 million. This keeps the focus squarely on how quickly the business can tighten its margins. The company has seen quarterly revenue move from $179.1 million in Q3 2025 to $190.8 million in Q2 2026 and then $197.1 million in Q3 2026. Over the same stretch, EPS has swung from -$0.86 to $0.48 and back to -$0.86, underscoring how choppy...

Wondering if Avery Dennison is quietly turning into a value opportunity after a choppy run in the market? Let us unpack what the current share price is really implying about its future. The stock closed at $172.22 recently, up 1.0% over the last week, but still down 1.5% over 30 days and 6.0% year to date, with a 13.9% slide over the past year while still holding a 20.5% gain over five years. Recent coverage has focused on Avery Dennison's strategic push in high value label and materials...

Cango (CANG) has just posted its Q3 2025 results, reporting total revenue of $224.6 million and net income of $37.3 million. Looking back, the company saw total revenue grow from 8.9 million CNY in Q1 2024 to 145.2 million CNY in Q1 2025, with net income shifting from 12.5 million CNY in Q1 2024 to a net loss of 28.6 million CNY in Q1 2025. With margins under pressure and profitability still a challenge, investors will be closely watching for signs of sustained top-line expansion in the face...

Ever wondered if Klaviyo is worth putting on your watchlist, or if there's hidden value behind the latest share price? Klaviyo’s stock has seen a steady 10.4% climb over the last month, even though it's still down 31.1% year-to-date. This trend suggests investors are re-evaluating its prospects and risk profile. Recent headlines have highlighted growing partnerships and product enhancements, which are fueling conversations among analysts and contributing to recent price momentum. Major...

Curious whether Standex International's stock is priced for opportunity or risk? You are not alone, and today we are diving into what the numbers really say. The stock has seen a 28.5% gain year-to-date and boasts a 217.5% return over the past five years, reflecting a record of long-term growth. Recent announcements around strategic acquisitions and expansion into new markets have caught investor attention, supporting both recent price momentum and optimism for the company's future...

Wondering whether Hut 8 stock is actually a good value right now? You are not alone, and we are here to break down what makes this company a standout or a stay-away from a valuation perspective. Hut 8’s share price has surged by an impressive 99.0% year-to-date and is up 73.9% over the past year, but the last month saw a -14.0% decline, which may have shifted perceptions around risk or opportunity. Recent news has been buzzing about Hut 8’s strategic initiatives to expand its digital asset...

Global Payments Inc. ( NYSE:GPN ) has announced that it will pay a dividend of $0.25 per share on the 26th of December...